CLINICAL

Atopic dermatitis: Biologics to watch in 2018In this article, we take a look at the development of new treatments for atopic dermatitis.
Recommendations for systemic therapy in eczema New recommendations from the International Eczema Council aim to address a question that has gone largely unanswered: When should dermatologists and others prescribe systemic therapy to treat atopic dermatitis?
Volatility in atopic dermatitis can impede treatment course“Because atopic dermatitis is episodic, its incidence, prevalence, persistence, remission, flare and long-term control require careful definition,” researchers write.
11 of the Weirdest Medical Facts Ever Believed
11 of the Weirdest Medical Facts Ever BelievedFrom the Drug Topics archives, one of most popular features in our history returns.
Colorscience introduces Clinical Redness CorrectorAll Calm™ Clinical Redness Corrector is formulated for redness, rosacea and sensitive skin, according to the company.
Manuka honey tested as AD treatmentA pilot study shows that Manuka honey may have some healing properties in atopic dermatitis.
An AD treatment phobia that is a “phenomenon”Atopic dermatitis patients have a phobia of topical corticosteroids that is so strong, it’s been described as a “phenomenon.”
Atopic dermatitis phenotypes may indicate outcomes
Atopic dermatitis phenotypes may indicate outcomesChildren under two years old with signs of atopic dermatitis have an increased risk of developing asthma and food allergies, researchers report in JAMA Pediatrics. And, young children with both early onset atopic dermatitis and a food allergy, have a “very high risk” of developing asthma or allergic rhinitis.
Patch testing remains underreported
Patch testing remains underreportedPatch testing for allergic contact dermatitis in the pediatric population is performed at a higher rate than previously reported, but still grossly underreported, according to a study of the Pediatric Contact Dermatitis Registry.
Antimicrobials approved for children’s skin infectionsFor the first time in a decade, there are antibiotics newly approved for use in children with skin and skin structure infections that do not respond to conventional treatment.

Poll

View Results